RARE filings
Corporate insider profile
Howard Horn Filing Activity
Latest reported as Chief Financial Officer of Ultragenyx Pharmaceutical Inc. (RARE).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$227,208.51
- Latest transaction
- Jun 1, 2026
Affiliated corporations
Reported company relationships
Transaction history
